Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KCT0002061Phase 4Recruiting
Phase 4 trial of esmolol in ocular hypertension, sponsored by Seoul St. Mary's Hospital. Primary endpoint: Intraocular pressure change. Started Jan 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on KCT0002061.